Madrigal Pharmaceuticals, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $117.6M | $754.4M | $100.0M |
| FY2025 | $339.9M | $602.7M | $198.7M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2024 | $117.6M | $754.4M | $100.0M |
| FY2025 | $339.9M | $602.7M | $198.7M |